In this article (the first of a two-part interview), Benjamin Djulbegovic, MD, PhD, discusses the uncertainty principle in clinical trials, a subject he has written about in The Lancet and elsewhere. Dr. Djulbegovic is associate professor of medicine, Divisions of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa.
Oncology News International: What is uncertainty?
Dr. Djulbegovic: Uncertainty is inherent in clinical medicine, although many physicians are unwilling to recognize it. It is this need for certainty that leads to excessive diagnostic testing and inappropriate treatments, which result in ballooning health care costs. Uncertainty can have many grades. It can range from complete ignorance to simply not knowing, say, about the relative benefits and harms of the treatment alternatives.
Our relationship toward uncertainty is an epistemological problem. For example, the uncertainty that we are discussing here—experimental testing within the context of clinical trials—is defined by our previous knowledge (and the quality of that knowledge) such as the existence of available evidence, experience, and biological plausibility about a given treatment. Ludmerer has recently made a compelling case that the failure to train clinicians properly for clinical uncertainty was the greatest deficiency of medical education throughout the 20th century.
ONI: What are the tools used to resolve these uncertainties?
Dr. Djulbegovic: In general, we can deal with uncertainty in several ways, all of which will fundamentally depend on our preexisting knowledge about the value of the treatments to be compared.
In some cases, preexisting knowledge can be accurate, based solely on the experience and inferences of individual practitioners, as, for example, the use of penicillin in the treatment of pneumococcal infections. Reliance on physician experience may also lead to false resolution of the uncertainty, however, such as the 200-year practice of venesection for treatment of bacterial infections.
Begg CB, Cho MD, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 276:637-639, 1996.
Bradford-Hill A et al: Clinical trials and the acceptance of uncertainty. Br Med J 294:1419, 1987.
Bradford-Hill A: Medical ethics and controlled trials. Br Med J 2:1043-1049, 1963.
Colditz GA, Miller JN, Mosteller F, et al: How study design affects outcomes in comparisons of therapy: I. Medical. Stat Med 8:441-454, 1989.
Djulbegovic B, Bennett CL, Adams JR, et al: Industry-sponsored research (reply to letters). Lancet 356:2193-2194, 2000.
Djulbegovic B, Clarke M, et al: Scientific and ethical issues in equivalence trials. JAMA 285:1206-1208, 2001.
Djulbegovic B, Hozo I, Abdomerovic I, et al: Diagnostic entropy as a function of therapeutic benefit/risk ratio. Med Hypotheses 45:503-509, 1995.
Djulbegovic B, Lacevic M, Cantor A, et al: The uncertainty principle and industry-sponsored research. Lancet 356:635-638, 2000.
Freedman B et al: Equipoise and the ethics of clinical research. N Engl J Med 317:141-145, 1987.
Gilbert JP, McPeek B, Mosteller F, et al: Statistics and ethics in surgery and anesthesia. Science 198:684-689, 1977.
Johnson N, Lilford JR, Brazier W, et al: At what level of collective equipoise does a clinical trial become ethical? J Med Ethics 17:30-34, 1991.
Lilford RJ, Djulbegovic B: Equipoise and uncertainty principle are not mutually exclusive (letter). Br Med J 322:795, 2001.
Lilford RJ, Djulbegovic B, et al: Equipoise is essential principle of human experimentation (letter). Br Med J 322:299-300, 2001.
Ludmerer KM: Time to Heal: American Medical Education From the Turn of the Century to the Era of Managed Care. New York, Oxford Press, 1999.
Machin D, Stenning S, Parmar M, et al: Thirty years of Medical Research Council randomized trials in solid tumors. Clin Oncology 9:100-114, 1997.
Martin JB, Kasper DL, et al: In whose best interest? Breaching the academic-industrial wall. N Engl J Med 343:1646-1649, 2000.
Mathe G, Brienza S, et al: From methodology to ethics and from ethics to methodology. Biomed & Pharmacother 42:143-153, 1988.
Matthews JR et al: Quantification and the Quest for Medical Certainty. Princeton, NJ, Princeton University Press, 1995.
Sackett DL, Hoey J, et al: Why randomized controlled trials fail but needn’t: A new series is launched. CMAJ 162:1301-1302, 2000.
World Medical Association: World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. JAMA 284:3043-3045, 2000.